Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

Lancet

Volumn 349, Issue 9057, 1997, Pages 986-990

  Waterworth, Dawn M ^a,e   Bennett, Simon T ^b   Gharani, Neda ^a   McCarthy, Mark I ^a   Hague, Stephen ^a   Batty, Sari ^a   Conway, Gerard S ^d   White, Davinia ^a   Todd, John A ^b   Franks, Stephen ^a   Williamson, Robert ^c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MIDDLESEX HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; CHROMOSOME 11P; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0030895556     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08368-7     Document Type: Article

References (32)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-61.
2. Conway GS, Agrawal R, Betteridge DJ, et al. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37: 119-25.
3. Dahlgren E, Johannson S, Lindstedt G. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertility Steril 1992; 57: 505-13.
4. Dahlgren E, Janson PO, Johansson S, et al. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective study of women. Acta Obstet Gynecol Scand 1992; 71: 599-604.
5. Robinson S, Kiddy D, Gelding SV, et al. The relationship of insulin sensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351-55.
6. Conway GS, Jacobs HS, Holly JMP, et al. Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin Endocrinol 1990; 33: 593-603.
7. Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-74.
8. Dunaif A, Segal KR, Shelley DR, et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41: 1257-66.
9. Holte J, Bergh T, Berne C, et al. Restored insulin sensitivity but persitently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80: 2586-93.
10. O'Meara N, Blackman JD, Ehrmann DA, et al. Defects in B-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1241-47.
11. Kiddy DS, Sharp PS, White D, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases. Clin Endocrinol 1990; 32: 213-20.
12. Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105-11.
13. Carey AH, Chan KL, Short F, et al. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocr 1993; 38: 653-58.
14. Bennett ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-92.
15. Bennett ST, Wilson AJ, Cucca F, et al. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 1996; 9: 415-21.
16. Vafiadis P, Bennett ST, Colle E, et al. Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes. J Autoimmun 1996; 9: 397-403.
17. Kennedy GC, German MS, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 1995; 9: 293-98.
18. Lucassen AM, Screaton GR, Julier C, et al. Regulation of insulin gene expression by IDDM associated, insulin gene locus haplotype. Hum Molec Genet 1995; 4: 501-06.
19. Owerbach D, Gabbay KH. The search for IDDM susceptibility genes: the next generation. Diabetes 1996; 45: 544-51.
20. Weaver JU, Kopelman PG, Hitman GA. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. Eur J Clin Invest 1992; 22: 265-70.
21. Bennett ST, Todd JA. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 1996; 30: 343-70.
22. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986; 293: 355-59.
23. Tadokoro K, Fujii H, Inoue T, et al. Polymerase chain reaction (PCR) for detection of ApaI polymorphism at the insulin like growth factor II gene (IGF2). Nucl Acids Res 1991; 19: 6967.
24. Kruglyak L, Daly MJ, Reeve-Daly MP, et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-63.
25. Thomson G. Mapping disease genes : family-based association studies. Am J Hum Genet 1995; 57: 487-98.
26. Baird DT, Corker CS, Davidson DW, et al. Pituitary-ovarian relationships in polycystic ovary syndrome. J Clin Endocrinol Metab 1977; 45: 798-801.
27. Poretsky L. Insulin resistance and hyperandrogenism: update 1994. Endocr Rev 1994; 2: 125-29.
28. Sharp PS, Kiddy DS, Reed M, et al. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin Endocrinol Metab 1991; 35: 253-57.
29. Willis D, Mason H, Gilling-Smith C, et al. Modulation by insulin of follicle stimulating hormone and luteinizing hormone action in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 302-09.
30. Dunaif A, Scott D, Finegood D, et al. The insulin sensitizing agent troglitazone improves the metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 3299-306.
31. Giddings SJ, King CD, Harman KW, et al. Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nat Genet 1994; 6: 310-13.
32. Hales CN, Barker DJP. Type 2 (non-insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.